Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
June 8, 2018
Zealand Pharma achieves milestone in first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes
Copenhagen, 8 June, 2018 - Zealand Pharma A/S ("Zealand") announces that the primary and key secondary objectives of the first multinational Phase 3 clinical trial of ...
June 8, 2018
Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
BOSTON, June 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
June 8, 2018
ADMA Biologics Announces Pricing of Public Offering of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., June 08, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”) announced today the pricing of ...
June 8, 2018
Oncobiologics Closes Second Tranche of $15 Million Private Placement
CRANBURY, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) (the “Company”) today announced that it has closed on the second, and final, tranche ...
June 7, 2018
Lipocine Announces Dosing in Ambulatory Blood Pressure Study for TLANDO™
SALT LAKE CITY, June 7, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced the dosing of the first subject in the ambulatory ...
June 7, 2018
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder
HACKENSACK, N.J., June 07, 2018 (GLOBE NEWSWIRE) --  Brainsway Ltd. (BRIN.TA), a leader in the advanced non-invasive treatment of brain disorders, and Cohen Veterans Bioscience, ...
June 7, 2018
MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension Advancing Development to Next Phase
WESTLAKE VILLAGE, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) today announced that it has completed a Phase 1 clinical study of Treprostinil ...
June 7, 2018
Paratek Demonstrates Breadth of Omadacycline Clinical and Microbiological Data at ASM Microbe 2018
BOSTON, June 07, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) announced today that data from its omadacycline clinical and microbiology programs will be presented ...
June 7, 2018
ADMA Biologics Announces Proposed Public Offering of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., June 07, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”) announced today that it has ...
June 7, 2018
Inspire Medical Systems, Inc. Reports First Quarter 2018 Financial Results
MINNEAPOLIS, June 07, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative ...
June 7, 2018
AIT Therapeutics Announces Change to Fiscal Year End and Financial Results Conference Call and Webcast for the Three Months Ended March 31, 2018
NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the ...
June 7, 2018
EDAP TMS SA : EDAP Announces FDA Clearance for Focal One®
AUSTIN, TX, LYON, FRANCE -- JUNE 7, 2018 -- EDAP TMS SA (EDAP) ("the Company"), the global leader in therapeutic ultrasound, today announced that it ...
June 6, 2018
VBL Therapeutics Presents Positive Data on its MOSPD2 Platform Technology in Oncology and Inflammation at BIO 2018
TEL AVIV, Israel, June 05, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT) today presented data on its novel MOSPD2 program in oncology and inflammation at the ...
June 6, 2018
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
SAN DIEGO and TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
June 6, 2018
MannKind Establishes Market Price Stock Purchase Plan
WESTLAKE VILLAGE, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) has established a stock purchase plan that provides MannKind’s directors and executive officers ...
June 6, 2018
Sensorion Announces Oral Presentation at the 15th International Conference on Cochlear Implants and Other Implantable Auditory Technologies (Ci2018)
MONTPELLIER, France, June 06, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, will present ...
June 6, 2018
iCAD Named 2018 MedTech Breakthrough Award Winner
NASHUA, N.H., June 06, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that ...
June 6, 2018
Avenue Therapeutics to Host Key Opinion Leader Call on Intravenous (IV) Tramadol for the Management of Postoperative Pain
NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (ATXI) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, ...
June 5, 2018
Opiant Pharmaceuticals to Participate in Opioid Panel at the BIO International Convention
SANTA MONICA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced ...
June 5, 2018
Molecular Templates Presents Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
AUSTIN, Texas, June 04, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM), a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
Page 55 of 138